Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 17,645 | 16,904 | 20,623 | 11,425 | 11,642 |
| Cost of Goods | 11,718 | 12,466 | 7,461 | 8,299 | 8,966 |
| Gross Profit | 5,927 | 4,438 | 13,162 | 3,126 | 2,676 |
| Operating Expenses | 25,973 | 22,798 | 22,036 | 21,727 | 21,887 |
| Operating Income | -19,328 | -17,894 | -8,413 | -18,302 | -18,245 |
| Interest Expense | 697 | 725 | 716 | 701 | 686 |
| Other Income | -148 | -356 | -34 | -133 | 45 |
| Pre-tax Income | -20,173 | -18,975 | -9,163 | -19,136 | -18,886 |
| Net Income Continuous | -20,173 | -18,975 | -9,163 | -19,136 | -18,886 |
| Net Income | $-20,173 | $-18,975 | $-9,163 | $-19,136 | $-18,886 |
| EPS Basic Total Ops | -0.27 | -0.26 | -0.13 | -0.27 | -0.28 |
| EPS Basic Continuous Ops | -0.27 | -0.26 | -0.13 | -0.27 | -0.28 |
| EPS Diluted Total Ops | -0.27 | -0.26 | -0.13 | -0.27 | -0.28 |
| EPS Diluted Continuous Ops | -0.27 | -0.26 | -0.13 | -0.27 | -0.28 |
| EBITDA(a) | $-18,200 | $-16,770 | $-7,209 | $-17,019 | $-16,842 |